Executive Team

dscn3807_crop

Chris Heylman, PhD

Chief Executive Officer

Dr. Christopher Heylman received his Ph.D. in Biomedical Engineering from Case Western Reserve University and was a George E. Hewitt Foundation for Medical Research Postdoctoral Fellow at University of California, Irvine.  His expertise in fluorescent microscopy and biological microfluidics has garnered numerous scientific publications in top tier journals.  He has received funding from multiple prestigious agencies including the National Institutes of Health, the Department of Defense, and the Lerner Research Institute.  His capacity for innovation was recognized as a recipient of the Cleveland Clinic Innovator Award.  Dr. Heylman co-founded Velox Biosystems to pursue his vision of enabling physicians to rapidly identify and treat a wide-range of diseases using Velox’s IC3D technology.
Byron professional portrait lighter background

Byron Shen, PhD MBA

Chief Commercial Officer

Dr. Byron Shen received his PhD in chemistry from U.C. Berkeley and his MBA from Carlson School of Business at University of Minnesota. Dr. Shen is a seasoned business leader with demonstrated success building businesses in the U.S. and globally in the medical device, biotech and pharmaceutical industries. Dr. Shen has worked both at small companies and Fortune 100 company like 3M. In his previous position as the Managing Director of DSI China, he successfully built a high performing China/Asia subsidiary from the ground up, and consistently delivered double digit annual growth in Asia. Dr. Shen has extensive technical and business expertise, wide-ranging medical domain knowledge, and is a businessperson, technologist, and writer in combination.